logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
R

Roger Echols

shionogi & company limited

44H指数
219论文数
7.1K被引数
收录论文 41
发表时间
logo
In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019 (vol 66, e01990-21, 2022)
errANTIMICROBIAL AGENTS AND CHEMOTHERAPY
IF4.5
err2023-06-15
err0
errOAAI
errKarlowsky, James A.; Hackel, Meredith A.; Takemura, Miki; Yamano, Yoshinori; Echols, Roger; Sahm, Daniel F.
err分享
err收藏
In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii
errJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
IF3.6
err2023-02-13
err16
errOAAI
errGill, Christian M.; Santini, Debora; Takemura, Miki; Longshaw, Christopher; Yamano, Yoshinori; Echols, Roger; Nicolau, David P.
err分享
err收藏
Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase-Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2022-02-11
err64
errOAAI
errTimsit, Jean-Francois; Paul, Mical; Shields, Ryan K.; Echols, Roger; Baba, Takamichi; Yamano, Yoshinori; Portsmouth, Simon
err分享
err收藏
Iron serum levels and iron homeostasis parameters in patients with nosocomial pneumonia treated with cefiderocol: post hoc analysis of the APEKS-NP study
errEUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
IF3
err2022-01-13
err5
errOAAI
errSkaar, Eric P.; Echols, Roger; Matsunaga, Yuko; Menon, Anju; Portsmouth, Simon
err分享
err收藏
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies碳青霉烯类耐药革兰阴性菌感染成人全因死亡率: 以病原体为重点的前瞻性、随机、干预性临床研究综述
errEXPERT REVIEW OF ANTI-INFECTIVE THERAPY
IF3.8
err2022-01-12
err38
errOAAI
errLodise, Thomas P.; Bassetti, Matteo; Ferrer, Ricard; Naas, Thierry; Niki, Yoshihito; Paterson, David L.; Zeitlinger, Markus; Echols, Roger
err分享
err收藏
Structured patient interview to assess clinical outcomes in complicated urinary tract infections in the APEKS-cUTI study: pilot investigation
errTHERAPEUTIC ADVANCES IN INFECTIOUS DISEASE
IF3.4
err2021-11-24
err2
errOAAI
errPortsmouth, Simon; Echols, Roger; Toyoizumi, Kiichiro; Tillotson, Glenn; Den Nagata, Tsutae
err分享
err收藏
HAP, VAP, AND HCAP PATIENTS IN THE APEKS-NP CLINICAL TRIAL HAD SIMILAR GRAM-NEGATIVE MICROBIOLOGY: MORTALITY WAS DRIVEN BY VENTILATION STATUS
errCHEST
IF8.6
err2021-10-01
err0
errOAAI
errEchols, Roger; Wunderink, Richard; Shorr, Andrew; Kollef, Marin; Menon, Anju
err分享
err收藏
Population Pharmacokinetic and Pharmacokinetic/ Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection肺炎，血流感染/败血症或复杂尿路感染患者的肠胃外铁载体头孢菌素头孢地洛尔的群体药代动力学和药代动力学/药效学分析
errANTIMICROBIAL AGENTS AND CHEMOTHERAPY
IF4.5
err2021-02-17
err66
errOAAI
errKawaguchi, Nao; Katsube, Takayuki; Echols, Roger; Wajima, Toshihiro
err分享
err收藏
Heterogeneity of Recent Phase 3 Complicated Urinary Tract Infection Clinical Trials
errOPEN FORUM INFECTIOUS DISEASES
IF3.8
err2021-02-02
err7
errOAAI
errPortsmouth, Simon; Bass, Almasa; Echols, Roger; Tillotson, Glenn
err分享
err收藏
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial头孢地洛尔与大剂量，延长输注美罗培南治疗革兰氏阴性医院肺炎 (APEKS-NP): 一项随机，双盲，3期，非劣效性试验
errLANCET INFECTIOUS DISEASES
IF31
err2021-02-01
err310
PREAI
errWunderink, Richard G.; Matsunaga, Yuko; Ariyasu, Mari; Clevenbergh, Philippe; Echols, Roger; Kaye, Keith S.; Kollef, Marin; Menon, Anju; Pogue, Jason M.; Shorr, Andrew F.; Timsit, Jean-Francois; Zeitlinger, Markus; Nagata, Tsutae D.
err分享
err收藏
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial头孢地洛尔或最佳可用疗法治疗耐碳青霉烯类革兰氏阴性菌引起的严重感染的疗效和安全性 (可信-CR): 一项随机、开放标签、多中心、以病原体为重点、描述性的3期试验
errLANCET INFECTIOUS DISEASES
IF31
err2021-02-01
err501
PREAI
errBassetti, Matteo; Echols, Roger; Matsunaga, Yuko; Ariyasu, Mari; Doi, Yohei; Ferrer, Ricard; Lodise, Thomas P.; Naas, Thierry; Niki, Yoshihito; Paterson, David L.; Portsmouth, Simon; Torre-Cisneros, Julian; Toyoizumi, Kiichiro; Wunderink, Richard G.; Nagata, Tsutae D.
err分享
err收藏
US FDA's Assessment of the Benefit-risk of Cefiderocol for its Initial Complicated Urinary Tract Infection Indication
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2021-01-07
err1
errOAAI
errEchols, Roger M.; Nagata, Tsutae
err分享
err收藏
In vitro activity of the siderophore cephalosporin, cefiderocol, against molecularly characterized, carbapenem-non-susceptible Gram-negative bacteria from Europe
errJAC-ANTIMICROBIAL RESISTANCE
IF3.3
err2020-08-25
err54
errOAAI
errLongshaw, Christopher; Manissero, Davide; Tsuji, Masakatsu; Echols, Roger; Yamano, Yoshinori
err分享
err收藏
The Burden of Bloodstream Infections due to Stenotrophomonas Maltophilia in the United States: A Large, Retrospective Database Study
errOPEN FORUM INFECTIOUS DISEASES
IF3.8
err2020-04-22
err51
errOAAI
errCai, Bin; Tillotson, Glenn; Benjumea, Darrin; Callahan, Patrick; Echols, Roger
err分享
err收藏
Pathogen-focused Clinical Development to Address Unmet Medical Need: Cefiderocol Targeting Carbapenem Resistance
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2019-11-13
err27
errOAAI
errEchols, Roger; Ariyasu, Mari; Den Nagata, Tsutae
err分享
err收藏
Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin新型铁载体头孢菌素头孢地洛尔的药代动力学和药效学特征
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2019-11-13
err78
errOAAI
errKatsube, Takayuki; Echols, Roger; Wajima, Toshihiro
err分享
err收藏
Difficult to Treat: Do We Need a New Definition?
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2019-03-06
err10
PREAI
errEchols, Roger M.; Tillotson, Glenn S.
err分享
err收藏
Efficacy of Humanized Cefiderocol Exposures over 72 Hours against a Diverse Group of Gram-Negative Isolates in the Neutropenic Murine Thigh Infection Model
errANTIMICROBIAL AGENTS AND CHEMOTHERAPY
IF4.5
err2019-02-01
err30
errOAAI
errStainton, Sean M.; Monogue, Marguerite L.; Tsuji, Masakatsu; Yamano, Yoshinori; Echols, Roger; Nicolau, David P.
err分享
err收藏
Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
errJOURNAL OF INFECTIOUS DISEASES
IF4.5
err2019-01-11
err50
errOAAI
errTalbot, George H.; Das, Anita; Cush, Stephanie; Dane, Aaron; Wible, Michele; Echols, Roger; Torres, Antoni; Cammarata, Sue; Rex, John H.; Powers, John H.; Fleming, Thomas; Loutit, Jeffrey; Hoffmann, Steve; Alder, Jeff; Ariyasu, Mari; Boucher, Helen; Cammarata, Sue; Connolly, Lynn; Cush, Stephanie; Dane, Aaron; Das, Anita; De Anda, Carisa; Dixon, Dennis; Dudley, Mike; Echols, Roger; Ehlert, Janet; Eisenstein, Barry; Eisner, Mark; File, Thomas; Fleming, Thomas R.; Follmann, Dean; Friedland, H. David; Friedland, Ian; Hoffmann, Steve; Horga, Maria Arantxa; Howard, Kellee; Kartsonis, Nicholas A.; Kaufhold, Achim; Kindrick, Amy; Llorens, Lily; Loutit, Jeff; McGovern, Paul; Powers, John H.; Prokocimer, Philippe; Rex, John H.; Seltzer, Elyse; Sherman, Claire; Suffredini, Anthony; Torres, Antoni; Tsai, Larry; Wunderink, Richard
err分享
err收藏
Cefiderocol for treatment of complicated urinary tract infections
errLANCET INFECTIOUS DISEASES
IF31
err2019-01-01
err6
errOAAI
errPortsmouth, Simon; Echols, Roger; Den Nagata, Tsutae
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
D
David L. Paterson
H 指数: 131 · 论文数: 955
M
Marin H. Kollef
H 指数: 128 · 论文数: 906
M
Matteo Bassetti
H 指数: 113 · 论文数: 1.0K
A
Antoní Torres
H 指数: 111 · 论文数: 1.4K
J
Jean‐François Timsit
H 指数: 101 · 论文数: 710
查看更多